Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  recombinant EphB4-HSA fusion protein
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab in Treating Patients with Metastatic or Recurrent Urothelial Cancer That Is Refractory to Certain Chemotherapy Drugs
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 4B-15-11, NCI-2016-00147, NCT02717156
EphB4-HSA in Treating Patients with Kaposi Sarcoma
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AMC-096, NCI-2015-00052, 096, NCT02799485
Recombinant EphB4-HSA Fusion Protein in Treating Patients with Metastatic or Recurrent Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0C-11-3, NCI-2012-00971, NCT01642342
Recombinant EphB4-HSA Fusion Protein with Standard Chemotherapy Regimens in Treating Patients with Advanced or Metastatic Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0S-15-5, NCI-2015-00987, NCT02495896
sEphB4-HSA before Surgery in Treating Patients with Bladder Cancer, Prostate Cancer, or Kidney Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0S-15-6, NCI-2015-02236, NCT02767921
Start Over